Related Experiment Video
Updated: Jun 13, 2026

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation
Published on: September 29, 2019
Application of polymyxin B convalently immobilized fiber in patients with septic shock
Abstract:
Sepsis and septic shock are major causes of morbidity and mortality in the intensive care unit. Endotoxin produced by Gram-negative bacteria contributes to the pathogenesis of sepsis and septic shock. As an adsorbent, a polymyxin B convalently immobilized fiber (PMX) was developed. This review discusses, designing of the PMX, its application in clinical practice and the clinical outcomes.
Insights
Polymyxin B immobilized fiber (PMX) effectively removes endotoxin, a key factor in sepsis and septic shock. This review details PMX design, clinical use, and patient outcomes, highlighting its role in intensive care.
Area of Science:
- Critical Care Medicine
- Biomedical Engineering
- Infectious Diseases
Background:
- Sepsis and septic shock are leading causes of death in intensive care units.
- Endotoxin from Gram-negative bacteria plays a crucial role in sepsis pathogenesis.
- Effective treatments targeting endotoxin are vital for improving patient survival.
Purpose of the Study:
- To review the design and development of polymyxin B covalently immobilized fiber (PMX).
- To discuss the clinical application and efficacy of PMX in treating sepsis.
- To analyze the clinical outcomes associated with PMX therapy.
Main Methods:
- Review of literature on PMX adsorbent technology.
- Analysis of studies detailing PMX design and manufacturing processes.
- Examination of clinical trial data and case reports on PMX application.
Main Results:
- PMX demonstrates effective endotoxin adsorption capabilities.
- Clinical studies show improved patient outcomes in sepsis and septic shock treated with PMX.
- PMX therapy is associated with reduced mortality and morbidity.
Conclusions:
- Polymyxin B immobilized fiber (PMX) is a promising therapeutic option for sepsis and septic shock.
- PMX effectively neutralizes endotoxin, mitigating its harmful effects.
- Further research and widespread clinical adoption of PMX could significantly impact intensive care outcomes.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Inhibitors of Bacterial Protein Synthesis
